“…Transdermal biosensing can bring us one step closer to personalized and precision medicine as it enables tracking of patient health conditions in a non- or minimally invasive manner. − Transdermal biosensors analyze interstitial fluid (ISF), the fluid which is present in the lowermost skin layer of the dermis, for biomarker measurements. − Compared to other body fluids, ISF has the most similar molecular composition to blood plasma, in addition to possessing other unique features including biomarkers of medical relevance. , Microneedle (MN)-based techniques have been introduced as a pain-free, minimally invasive, and easy-to-use ISF sampling approach with the potential of integrating diagnostics. − MNs with a needle length less than 1000 μm enable efficient skin penetration and ISF extraction. , Different types of MNs implement various strategies to obtain ISF, for example, hollow MNs operate based on negative pressure, , porous MNs use capillary force, , and the most recent one, hydrogel-based MNs (HMNs), employ material absorption property. , Compared to other MNs, HMNs possess several advantages, including increased and rapid ISF extraction, high biocompatibility, lower fabrication cost, higher production yield, and, most importantly, ease of insertion and removal without causing skin damage. ,,,, …”